| Style | Citing Format |
|---|---|
| MLA | Asadollahzade E, et al.. "The Benefits and Side Effects of Gadolinium-Based Contrast Agents in Multiple Sclerosis Patients." Revista da Associacao Medica Brasileira, vol. 68, no. 8, 2022, pp. 979-980. |
| APA | Asadollahzade E, Ghadiri F, Ebadi Z, Moghadasi AN (2022). The Benefits and Side Effects of Gadolinium-Based Contrast Agents in Multiple Sclerosis Patients. Revista da Associacao Medica Brasileira, 68(8), 979-980. |
| Chicago | Asadollahzade E, Ghadiri F, Ebadi Z, Moghadasi AN. "The Benefits and Side Effects of Gadolinium-Based Contrast Agents in Multiple Sclerosis Patients." Revista da Associacao Medica Brasileira 68, no. 8 (2022): 979-980. |
| Harvard | Asadollahzade E et al. (2022) 'The Benefits and Side Effects of Gadolinium-Based Contrast Agents in Multiple Sclerosis Patients', Revista da Associacao Medica Brasileira, 68(8), pp. 979-980. |
| Vancouver | Asadollahzade E, Ghadiri F, Ebadi Z, Moghadasi AN. The Benefits and Side Effects of Gadolinium-Based Contrast Agents in Multiple Sclerosis Patients. Revista da Associacao Medica Brasileira. 2022;68(8):979-980. |
| BibTex | @article{ author = {Asadollahzade E and Ghadiri F and Ebadi Z and Moghadasi AN}, title = {The Benefits and Side Effects of Gadolinium-Based Contrast Agents in Multiple Sclerosis Patients}, journal = {Revista da Associacao Medica Brasileira}, volume = {68}, number = {8}, pages = {979-980}, year = {2022} } |
| RIS | TY - JOUR AU - Asadollahzade E AU - Ghadiri F AU - Ebadi Z AU - Moghadasi AN TI - The Benefits and Side Effects of Gadolinium-Based Contrast Agents in Multiple Sclerosis Patients JO - Revista da Associacao Medica Brasileira VL - 68 IS - 8 SP - 979 EP - 980 PY - 2022 ER - |